Liraglutide as an alternative to insulin for glycemic control in intensive care unit: A randomized, open-label, clinical study

Conclusion: Liraglutide is a viable alternative to insulin for glycemic control in the ICU. Further studies with a larger number of patients are required to confirm our findings.

http://www.ijccm.org/text.asp?2017/21/9/568/214617

Source: Indian Journal of Critical Care Medicine - September 14, 2017 Category: Intensive Care Authors: Vishesh Verma Narendra Kotwal Vimal Upreti Monish Nakra Yashpal Singh K Anand Shankar Amit Nachankar K.V.S. Hari Kumar Source Type: research